Amarin Corporation plc ( AMRN) - Key Metrics
AMRN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.05 | $0 | $0.02 | $0.02 |
| 2025Q3 | $2.39 | -$0.37 | -$0.61 | -$0.61 |
| 2025Q2 | $3.51 | -$0.68 | $0.80 | $0.80 |
| 2025Q1 | $2.04 | -$0.76 | -$0.60 | -$0.60 |
AMRN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1186.14 |
| 2025Q3 | ? | -11.00 |
| 2025Q2 | ? | -5.94 |
| 2025Q1 | ? | -2.94 |
AMRN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.12% | ? |
| 2025Q4 | 5.26% | ? |
| 2025Q3 | -3.75% | ? |
| 2025Q2 | 4.94% | ? |
| 2025Q1 | -6.74% | ? |
AMRN
Price: $14.20
52 week price:
Earnings Per Share: -1.60 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Ireland
Volume: 2.2 million
Ebitda: -8.2 millionMarket Capitalization: 304.9 million